Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of voriconazole in critically ill ICU patients
2014-001222-15Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- May 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of voriconazole in invasive aspergillosis (IA), sponsored by University Medical Center Groningen. Primary endpoint: Primary: Voriconazole bioavailability < 80%. Started May 2014; status: active.
02
Drugs
voriconazole
03
Conditions
invasive aspergillosis (IA)
Beyond the preview
Go deeper on 2014-001222-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001222-15.